COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Dunlop Sports Americas Announces the Relaunch of Never Compromise Putters
Dunlop Sports Americas is thrilled to announce the relaunch of the iconic Never Compromise Reserve putter line, offering golfers a unique fitting method for an uncompromised putting experience. With precision-cut bespoke putter lengths, interchangeable sole weights, and stroke-specific models, the Never Compromise Reserve Putters are designed to provide golfers with personalized options for improved performance on the greens. Visit us.dunlopsports.com/never-compromise for more information. -
COMMUNIQUÉ DE PRESSE
Suzhou Pinyu Precision Mechanical Co., Ltd., Parent Company of SOTSU, Visited by SAP Greater China
Suzhou Pinyu Precision Mechanical Co., Ltd., welcomed Michael Locher-Tjoa, COO of SAP Greater China and introduced him to their vision of creating innovative products. The company recently launched SOTSU, maker of the world's first even-bezel portable monitor and the creator of the world's first popular manufacturing business Trading Card Game. Their CEO emphasized the commitment to excellence and digital transformation with SAP as a key partner. -
COMMUNIQUÉ DE PRESSE
Vicinity Motor Corp. Secures VMC 1200 Distribution Agreement with VMC Laval in Laval, Canada
Montreal-based electric vehicle dealership, Vicinity Motor Corp. (NASDAQ:VEV)(TSXV:VMC), expands into the commercial EV market with the launch of VMC Laval, a new dealership in partnership with Groupe Taddeo Auto. With a focus on fleet solutions for businesses and government, the dealership will distribute Vicinity VMC 1200 electric trucks throughout Montreal-Laval, aiming to capitalize on government incentives and the growing demand for commercial EVs. -
COMMUNIQUÉ DE PRESSE
New Study Published in Nature Scientific Reports Shows Industry-Leading Performance for Waymark Signal in Predicting Avoidable ER and Hospital Utilization
Waymark, the Medicaid provider enablement company, has published a peer-reviewed study in Nature's Scientific Reports demonstrating that Waymark Signal is 90 percent accurate in predicting avoidable emergency room and hospital visits for patients receiving Medicaid. The study found that Waymark Signal's machine learning approach outperformed traditional Medicaid risk models, identifying at-risk patients 3 times better and predicting costs 10 times better. The study also highlighted the reversal of Black-White prediction bias observed in most risk models, providing valuable guidance for addressing care disparities. Waymark works directly with Medicaid health plans and primary care providers to deliver technology-enabled, community-based care. The company's local care teams use Waymark Signal to identify and outreach patients at risk of avoidable ER and hospital utilization, paving the way for more accessible and equitable pathways to better health for underserved communities. -
COMMUNIQUÉ DE PRESSE
Equum Medical Aims to Revolutionize Rural Mississippi Healthcare Through Telehealth Excellence
Equum Medical announces a collaboration with the University of Mississippi Medical Center to address healthcare challenges in rural Mississippi through telehealth solutions. The initiative aims to improve healthcare accessibility and quality for underserved populations, particularly in the Delta Region. This strategic partnership combines the expertise of UMMC in telehealth with Equum Medical's dynamic virtual resourcing to provide essential care services and serve as a model for comprehensive telehealth integration. Learn more about Equum Medical at www.equummedical.com. -
COMMUNIQUÉ DE PRESSE
AI/ML Innovations Inc.’s Subsidiary, Health Gauge, Unveils Its Proprietary "The Pulse Whisperer" for Biometric Raw Signal Data to Empower Life Science Researchers
Health Gauge Inc. proudly announces the launch of its innovative product, 'The Pulse Whisperer' for Biometric Raw Signal Data. The Pulse Whisperer is a powerful tool designed for use by Life Science Researchers, providing them with unprecedented access to the raw biometric signals captured from smart sensor wearables, as well as the ability to utilize the raw data to help improve health outcomes through Health Gauge's unique and comprehensive suite of products. This product suite encompasses Health Gauge's Smart Sensor Wearables, Device Firmware, SDK & APIs, and licensed access to Health Gauge's Proprietary and Patented Neural Network technology, all coupled with Health Gauge's scalable Biometric Platform for Life Sciences. Researchers can now harness rich, previously inaccessible data, opening new frontiers in health research. -
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Aurubis AG: Company management to be restructured in 2024
Aurubis AG's company management is set to undergo restructuring in 2024 as the Supervisory Board has agreed to prematurely terminate the contracts of CEO Roland Harings, CFO Rainer Verhoeven, and COO Smelting & Products Dr. Heiko Arnold. This decision comes in light of the unique challenges faced by Aurubis, including serious cases of fraud and theft at the Hamburg plant and work safety incidents. The process for new appointments to the Executive Board has already begun, with Prof. Markus Kramer joining to assume key responsibilities initially until September 30, 2024. -
COMMUNIQUÉ DE PRESSE
Ørsted to present full-year results for 2023 on 7 February
Ørsted A/S is set to present its full-year results for 2023 on 7 February 2024. The presentation will be conducted by Mads Nipper, Group President and CEO, and Rasmus Errboe, interim CFO. The event will be available for in-person attendance as well as via live streaming. Ørsted will also host a phone press briefing for journalists to provide further details on the Capital Markets Update and annual results for 2023. Media and investor contacts are provided for more information. -
COMMUNIQUÉ DE PRESSE
Biotricity Expands Development of its Cardiac AI Cloud Platform with Data Ecosystem of over 360 billion Heartbeats
Biotricity Inc. (NASDAQ:BTCY) has announced the expansion of its Cardiac AI Cloud platform, aiming to develop predictive monitoring to identify issues before they occur, supporting earlier interventions, and reducing healthcare costs. The company's goal is to build comprehensive AI models for improved diagnoses and interventions, having analyzed over 360 billion heartbeats and helped diagnose over 200,000 patients. The development of large data models is crucial for supporting the intermittent nature of cardiac issues and the noisy data arising from ambulatory monitoring, and for helping cardiologists service more patients. The company's effort in building a comprehensive Cardiac AI Cloud platform aims to make cardiac care accessible, affordable, and scalable, thus providing necessary support and assistance to healthcare professionals. For more information, visit www.biotricity.com.
